William Blair Investment Management Sells Evolent Health Shares

Institutional investor reduces stake in healthcare technology company

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

William Blair Investment Management LLC decreased its holdings in Evolent Health, Inc. (NYSE:EVH) by 6.7% during the third quarter, according to a recent filing. The institutional investor now owns 4,035,475 shares of the technology company's stock, worth $34,140,000 as of its most recent SEC filing.

Why it matters

Evolent Health is a healthcare technology and services company that partners with health systems, physician organizations and health plans to design and operate value-based care programs. The reduction in shares held by a major institutional investor like William Blair could signal a shift in market sentiment or confidence around the company's future performance.

The details

According to the report, William Blair Investment Management sold 289,408 shares of Evolent Health during the third quarter. The institutional investor now holds a 6.7% smaller stake in the company compared to the prior quarter. Other large investors have also recently adjusted their positions in Evolent Health, with some adding to their holdings and others reducing exposure.

  • The share sale occurred during the third quarter of the company's fiscal year.
  • William Blair Investment Management filed its most recent 13F report with the SEC on March 2, 2026.

The players

William Blair Investment Management LLC

An institutional investment management firm based in Chicago, Illinois that manages over $100 billion in assets.

Evolent Health, Inc.

A healthcare technology and services company headquartered in Arlington, Virginia that partners with health systems, physician organizations and health plans to design and operate value-based care programs.

Got photos? Submit your photos here. ›

The takeaway

The reduction in shares held by a major institutional investor like William Blair could signal a shift in market sentiment or confidence around Evolent Health's future prospects, though the company's long-term fundamentals and growth strategy remain to be seen.